Showing results (401-410 of 423) with videos related to

Sort By:
Pageof 43
Computer Methods and Programs in Biomedicine|January 7, 2024
Isotropic multi-scale neuronal reconstruction from high-ratio expansion microscopy with contrastive unsupervised deep generative modelsGary Han Chang, Meng-Yun Wu, Ling-Hui Yen, et al.
World Journal of Gastroenterology|February 10, 2010
Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysisXin-Hua Qu, Xiao-Lu Huang, Ping Xiong, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trialKe-Da Yu, Xi-Yu Liu, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2019
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast CancerYi Xiao, Ding Ma, Shen Zhao, et al.
Cancer Letters|April 13, 2026
Integrated Genomic Profiling Identifies Predictive Biomarkers for Neoadjuvant Therapy Response in Chinese Breast Cancer PatientsXiao-Han Ying, Kun-Yu Zhang, Shu-Hao Jiang, et al.
Molecular Plant|September 5, 2025
OsSPT38 encodes a novel SUMO E3 ligase that enhances rice stress resilience and grain yieldZi-Sheng Zhang, Zheng-Yi Zhang, Jin-Qiu Xia, et al.
BMJ (Clinical Research Ed.)|December 23, 2025
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trialYin Liu, Yue Gong, Xiu-Zhi Zhu, et al.
Acta Pharmacologica Sinica|August 3, 2021
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myelomaYu-Bo Zhou, Yang-Ming Zhang, Hong-Hui Huang, et al.
Cell Research|March 27, 2023
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trialYin Liu, Xiu-Zhi Zhu, Yi Xiao, et al.
Science Advances|March 12, 2019
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradationXi Jin, Xiao-En Xu, Yi-Zhou Jiang, et al.
Pageof 43